Allena Pharmaceuticalsincis A Late Stage Biopharmaceutical Company Based In Newtonmassachusettsfounded In 2011The Company Specializes In Developing And Commercializing First In Class Oral Enzyme Therapeutics Aimed At Treating Rare And Severe Metabolic And Kidney Disorders The Company S Lead Product Candidatereloxaliaseis In A Pivotal Phase 3 Clinical Program For Enteric Hyperoxaluriaa Condition Linked To Elevated Urinary Oxalate Levels And Associated With Kidney Stones And Chronic Kidney Diseaseanother Significant Candidatealln 346Is A Novel Urate Degrading Enzyme Currently Undergoing Phase 2A Trials For Hyperuricemia And Gout In Patients With Advanced Chronic Kidney Disease
